These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 227534

  • 1. Biochemical characterization of postsynaptically localized cyclic nucleotide phosphodiesterase.
    Ariano MA, Appleman MM.
    Brain Res; 1979 Nov 16; 177(2):301-9. PubMed ID: 227534
    [Abstract] [Full Text] [Related]

  • 2. [Phosphodiesterase of cyclic nucleotides].
    Etingof RN, Dumler IL.
    Ukr Biokhim Zh (1978); 1981 Nov 16; 53(2):28-43. PubMed ID: 6266102
    [Abstract] [Full Text] [Related]

  • 3. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
    Strada SJ, Thompson WJ.
    Adv Cyclic Nucleotide Res; 1978 Nov 16; 9():265-83. PubMed ID: 208379
    [No Abstract] [Full Text] [Related]

  • 4. Cyclic nucleotide phosphodiesterase from Spinacea oleracea L: subcellular distribution and properties [proceedings].
    Edwards M, Brown EG, Newton RP, Smith CJ.
    Biochem Soc Trans; 1977 Nov 16; 5(4):975-7. PubMed ID: 199507
    [No Abstract] [Full Text] [Related]

  • 5. Cyclic nucleotide phosphodiesterase activities of the human liver: comparison between control and Reye's syndrome samples.
    Kang ES.
    Pediatr Res; 1978 Jul 16; 12(7):761-6. PubMed ID: 211480
    [No Abstract] [Full Text] [Related]

  • 6. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B, Mantell K, Bacher B.
    Neurosci Lett; 1998 Aug 07; 252(1):57-60. PubMed ID: 9756358
    [Abstract] [Full Text] [Related]

  • 7. Cyclic nucleotide phosphodiesterase activity in normal mice and mice with retinal degeneration.
    Robb RM.
    Invest Ophthalmol Vis Sci; 1979 Oct 07; 18(10):1097-100. PubMed ID: 225287
    [No Abstract] [Full Text] [Related]

  • 8. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
    Osipenko AA, Prishchepa LA, Kurskiĭ MD.
    Ukr Biokhim Zh (1978); 1986 Oct 07; 58(4):26-31. PubMed ID: 3016961
    [Abstract] [Full Text] [Related]

  • 9. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
    Stefanovich V.
    Neurochem Res; 1979 Dec 07; 4(6):681-7. PubMed ID: 232543
    [Abstract] [Full Text] [Related]

  • 10. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R, Weiss B.
    Mol Pharmacol; 1976 Jul 07; 12(4):678-87. PubMed ID: 183099
    [No Abstract] [Full Text] [Related]

  • 11. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
    Goff AK, Major PW.
    FEBS Lett; 1976 Jan 15; 61(2):144-7. PubMed ID: 174943
    [No Abstract] [Full Text] [Related]

  • 12. [Relationship between cyclic nucleotide phosphodiesterases (cPDE) and some patho-biologic behaviors of stomach cancer--I. Histochemical studies of CPDE in stomach cancer tissues].
    Xin Y.
    Zhonghua Zhong Liu Za Zhi; 1989 Mar 15; 11(2):117-20. PubMed ID: 2553363
    [Abstract] [Full Text] [Related]

  • 13. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW.
    Biochim Biophys Acta; 1982 Jul 12; 705(1):1-7. PubMed ID: 6288105
    [Abstract] [Full Text] [Related]

  • 14. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW, Daly JW.
    Mol Pharmacol; 1980 Mar 12; 17(2):206-11. PubMed ID: 6248757
    [No Abstract] [Full Text] [Related]

  • 15. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ, Maurice DH.
    Mol Pharmacol; 2005 Jan 12; 67(1):263-72. PubMed ID: 15475573
    [Abstract] [Full Text] [Related]

  • 16. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H, Endo T.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Jan 12; 16():245-59. PubMed ID: 6144253
    [No Abstract] [Full Text] [Related]

  • 17. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J, Markerink-van Ittersum M, Vles JS.
    J Chem Neuroanat; 2006 Jun 12; 31(4):275-303. PubMed ID: 16621445
    [Abstract] [Full Text] [Related]

  • 18. Cyclic nucleotide phosphodiesterase activity in the mussel Mytilus edulis L. [proceedings].
    Abreu-Grobois FA, Newton RP, Smith CJ.
    Biochem Soc Trans; 1977 Jun 12; 5(5):1348-51. PubMed ID: 200501
    [No Abstract] [Full Text] [Related]

  • 19. Calcium-dependent cyclic nucleotide phosphodiesterase from brain: comparison of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate as substrates.
    Brostrom CO, Wolff DJ.
    Arch Biochem Biophys; 1976 Jan 12; 172(1):301-11. PubMed ID: 175742
    [No Abstract] [Full Text] [Related]

  • 20. Decreased adenosine cyclic 3',5'-monophosphate phosphodiesterase activity in rat straitum following chronic haloperidol treatment.
    Fredholm BB.
    Med Biol; 1977 Feb 12; 55(1):61-5. PubMed ID: 191703
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.